A randomised trial of high-flow nasal cannula in infants with moderate bronchiolitis

Conclusions
In patients with moderate bronchiolitis, there was no evidence of lower rate of escalating respiratory support among those receiving HFNC therapy.

Source: European Respiratory Journal - July 15, 2020 Category: Respiratory Medicine Authors: Durand, P., Guiddir, T., Kyheng, C., Blanc, F., Vignaud, O., Epaud, R., Dugelay, F., Breant, I., Badier, I., Degas-Bussiere, V., Phan, F., Soussan-Banini, V., Lehnert, A., Mbamba, C., Barrey, C., Tahiri, C., Decobert, M., Saunier-Pernaudet, M., Craiu, I., Tags: Paediatric pulmonology Original Articles: Paediatrics Source Type: research